These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14736948)

  • 1. Which dialyser membrane to choose?
    Bouré T; Vanholder R
    Nephrol Dial Transplant; 2004 Feb; 19(2):293-6. PubMed ID: 14736948
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodialysis catheters: materials, design and manufacturing.
    Wentling AG
    Contrib Nephrol; 2004; 142():112-27. PubMed ID: 14719389
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term vascular access: the Tesio catheter.
    Tesio F; Panarello G
    Contrib Nephrol; 2004; 142():153-8. PubMed ID: 14719391
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter?
    Grooteman MP; Nubé MJ
    Nephrol Dial Transplant; 2004 Dec; 19(12):2965-70. PubMed ID: 15507481
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular access for acute extracorporeal renal replacement therapies.
    Granata A; D'Intini V; Bellomo R; Ronco C
    Contrib Nephrol; 2004; 142():159-77. PubMed ID: 14719392
    [No Abstract]   [Full Text] [Related]  

  • 7. What clinically important advances in understanding and improving dialyzer function have occurred recently?
    Ward RA; Leypoldt JK; Clark WR; Ronco C; Mishkin GJ; Paganini EP
    Semin Dial; 2001; 14(3):160-74. PubMed ID: 11422918
    [No Abstract]   [Full Text] [Related]  

  • 8. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant?
    Upadhyay A; Jaber BL
    Semin Dial; 2017 Mar; 30(2):121-124. PubMed ID: 28066932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 11. Mid-dilution on-line haemodiafiltration in a standard dialyser configuration.
    Krieter DH; Collins G; Summerton J; Spence E; Moragues HL; Canaud B
    Nephrol Dial Transplant; 2005 Jan; 20(1):155-60. PubMed ID: 15522903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 14. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

  • 15. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
    Schiffl H; Fischer R; Lang SM; Mangel E
    Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The practical application of ozone in dialysis.
    Amato RL; Curtis J
    Nephrol News Issues; 2002 Sep; 16(10):27-30. PubMed ID: 12271927
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin clearance with high-flux dialysis membranes.
    Anandan JV; Touchette MA
    Int J Artif Organs; 1998 Mar; 21(3):131-3. PubMed ID: 9622110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.